fda glp-1 safety warning september 2025 Issues 30 Letters to Telehealth Firms Over Misleading Compounded Marketing GLP-1 Weight-Loss Drug Demonstration Begins

acknowledges support from the NIH NEI R15 EY029504, NIH NIDCR R01DE031812, NIH NIAMS R21AR079708, NIH NIAMS R01AR080895, NIH NIDCR R01DE029321, NIH NCATS UL1TR003017, and the Undergraduate Research and Innovation program at NJIT

Pairing GLP-1 therapy with the Precision Peptide Genetic Test ($99) gives you personalized insight into how your genetic makeup influences cholesterol metabolism, allowing your provider to optimize your treatment from day one

Testing empowers your prescriber to prescribe with precision rather than trial and error

William Thoms, who has served as the radiation oncology medical director for Wellstar Paulding Medical Center since 2017

This is very different from some older diabetes medications that force the pancreas to release insulin regardless of blood sugar levels, which can cause dangerous drops in blood sugar (hypoglycaemia)

These two conditions are interconnected, making the study of their shared neurobiological mechanisms fundamental to provide more effective interventions (Milaneschi et al., 2019)